Source: Homeland Preparedness News

Assistant Secretary for Preparedness and Response: BARDA supports Luminex single, rapid test to distinguish between flus, RSV and COVID-19 infections

The Biomedical Advanced Research and Development Authority (BARDA) and Luminex Corporation announced a collaboration on advanced development support of a single test to rapidly detect and differentiate between COVID-19, influenza, and respiratory syncytial virus (RSV). Prevalent pathogens all, being able ... Read More » The post BARDA supports Luminex single, rapid test to distinguish between flus, RSV and COVID-19 infections appeared first on Homeland Preparedness News.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25